Background and aims Immune response against hepatitis B virus (HBV) infection is an
important risk factor for the development of hepatocellular carcinoma (HCC). Studies have …

Interleukin (IL)-22 is a member of the IL-10 cytokine family and is secreted by activated T
cells, dendritic cells, and several different kinds of natural killer (NK)-like cells. 1 IL-22 …

Simple Summary Hepatocellular carcinoma (HCC) still poses a major challenge for curative
treatment. Although some new therapeutic options arose during the last decade, the overall …

Background: Interleukin-25 (IL-25) has been proved to play a role in the pathogenesis and
metastasis of Hepatocellular carcinoma (HCC), but the relationship between the level of IL …

AIM: To determine whether serum interleukin-18 (IL-18) levels correlated with
clinicopathologic features and prognosis in patients with hepatocellular carcinoma (HCC) …

Background There is no data regarding prognostic impact of interleukin (IL)-26 on outcomes
of patients with hepatocellular carcinoma (HCC). The present study aimed to evaluate the …

Abstract Background Interleukin-22 (IL-22) is a pro-inflammatory cytokine released during
the immune response in chronic liver injury. Although IL-22 mediates tissue regeneration, its …

Objective: The purpose of this retrospective study was to evaluate the diagnosis efficacy of
plasma interleukin 17 (IL-17) for hepatocellular carcinoma (HCC). Materials and Methods …

Background Hepatocellular carcinoma (HCC) is a typical malignancy in a background of
chronic inflammation. Th17 cells (a major source of IL-17) constitute crucial components of …

Background The role of interleukin (IL) 17A in chronic liver diseases had been extensively
studied, but the function of IL-17F, which shares a high degree of homology with IL-17A, in …